Mirae Asset Global Investments Co. Ltd. Increases Stock Position in Astera Labs, Inc. $ALAB

Mirae Asset Global Investments Co. Ltd. lifted its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 16,543.5% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 196,560 shares of the company’s stock after acquiring an additional 195,379 shares during the period. Mirae Asset Global Investments Co. Ltd. owned 0.12% of Astera Labs worth $38,486,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Whittier Trust Co. bought a new stake in Astera Labs in the third quarter worth $55,000. Grove Bank & Trust bought a new position in Astera Labs in the 3rd quarter valued at $68,000. Bernard Wealth Management Corp. purchased a new position in shares of Astera Labs in the 2nd quarter valued at $36,000. Cullen Frost Bankers Inc. boosted its position in Astera Labs by 1,560.0% during the third quarter. Cullen Frost Bankers Inc. now owns 415 shares of the company’s stock valued at $81,000 after purchasing an additional 390 shares in the last quarter. Finally, Clearstead Trust LLC grew its stake in Astera Labs by 46,100.0% in the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after purchasing an additional 461 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Down 1.8%

Astera Labs stock opened at $167.90 on Thursday. The company’s 50 day moving average is $163.38 and its two-hundred day moving average is $170.80. The firm has a market cap of $28.36 billion, a PE ratio of 151.26, a price-to-earnings-growth ratio of 2.33 and a beta of 1.50. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. During the same quarter in the previous year, the company posted $0.23 earnings per share. The firm’s revenue was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In other news, Director Manuel Alba sold 150,000 shares of the stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the completion of the transaction, the director directly owned 1,574,498 shares of the company’s stock, valued at approximately $261,650,077.64. This represents a 8.70% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Jitendra Mohan sold 90,459 shares of Astera Labs stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the sale, the chief executive officer owned 2,080,418 shares in the company, valued at approximately $301,015,680.42. This trade represents a 4.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 576,936 shares of company stock worth $87,409,540 in the last 90 days. Corporate insiders own 12.50% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently commented on ALAB shares. BNP Paribas Exane began coverage on shares of Astera Labs in a research note on Thursday, November 20th. They set an “outperform” rating for the company. TD Cowen restated a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Zacks Research cut Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Barclays set a $165.00 target price on Astera Labs in a research note on Thursday, January 15th. Finally, Raymond James Financial assumed coverage on shares of Astera Labs in a research note on Friday, November 21st. They set a “hold” rating on the stock. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $190.63.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.